Morphological and Microscopic Findings: Clinical Trials

4 trials for Morphological and Microscopic Findings, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Morphological and Microscopic Findings: new trials by email Literature Review of Morphological and Microscopic Findings trials Research Report on Morphological and Microscopic Findings

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
PVX-2, Placebo - ASC-US, ASC-H
Phase 2TerminatedPapiVax Biotech, Inc.162019-05-222024-06-17
Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer
Sunitinib, Everolimus - Metastatic Renal Cell Carcinoma
Phase 2TerminatedAssociació per a la Recerca Oncologica, Spain412013-02-122017-10-02
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
Biopsy, Laboratory Biomarker Analysis, Megestrol Acetate - High Grade Squamous Intraepithelial Neoplasia, Stage 0 Uterine Corpus Cancer
Phase 2TerminatedGynecologic Oncology Group92007-07-012020-11-03
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
851B - Papillomavirus Infections
Phase 2TerminatedTakeda5382006-04-012016-09-23

Narrower conditions

Atypical Squamous Cells of the Cervix (2)  ·  Carcinoma, Renal Cell (1)  ·  Margins of Excision (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Papillomavirus Infections (1)  ·  Squamous Intraepithelial Lesions (1)  ·  Uterine Cervical Dysplasia (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Urogenital Diseases (3)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Precancerous Conditions (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Adenocarcinoma (1)

Interventions

Biopsy (1)  ·  Everolimus (1)  ·  Megestrol Acetate (1)  ·  Sunitinib (1)

Sponsors

Associació per a la Recerca Oncologica, Spain (1)  ·  Gynecologic Oncology Group (1)  ·  PapiVax Biotech, Inc. (1)  ·  Takeda (1)

Countries

United States (3)  ·  Canada (1)  ·  France (1)  ·  Greece (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Joaquim Bellmunt, MD/PhD (1)  ·  Mark Einstein, MD, MS (1)  ·  Michael Method (1)

Results publications

PMID 32654362, PMID 36607735

NIH funding

U10CA101165 (1)